European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
European Human Genetics Conference 2007 June 16 – 19, 2007 ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Cancer genetics<br />
P0518. A map of nuclear matrix attachment regions within<br />
the breast cancer loss-of-heterozygosity region on human<br />
chromosome <strong>16</strong>q22.1<br />
S. Shaposhnikov 1 , S. Akopov 2 , I. Chernov 2 , L. Nikolaev 2 , E. Frengen 3 , A. Collins<br />
3 , V. Zverev 1 ;<br />
1 Institute of Viral Preparations, Moscow, Russian Federation, 2 Shemyakin and<br />
Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation,<br />
3 University of Oslo, Oslo, Norway.<br />
To explore the DNA domain organization of the breast cancer loss-ofheterozygosity<br />
region on human chromosome <strong>16</strong>q22.1, we have identified<br />
a significant portion of the scaffold/matrix attachment regions (S/<br />
MARs) within this region. Forty independent putative S/MAR elements<br />
were assigned within the <strong>16</strong>q22.1 locus. More than 90% of these S/<br />
MARs are AT rich, with GC contents as low as 27% in 2 cases. Thirtynine<br />
(98%) of the S/MARs are located within genes and 36 (90%) in<br />
gene introns, of which 15 are in first introns of different genes. The<br />
clear tendency of S/MARs from this region to be located within the<br />
introns suggests their regulatory role. The genomic interval mapped<br />
has been identified as a possible region harboring tumor suppressor<br />
genes in both invasive ductal and invasive lobular breast carcinomas.<br />
The E-cadherin gene, which is located within this region, has been<br />
shown to be mutated in lobular breast carcinomas, resulting in loss of<br />
E-cadherin expression. However, in most cases of ductal carcinoma,<br />
E-cadherin is normally expressed, suggesting that other genes within<br />
chromosome <strong>16</strong>q22.1 may be involved in the development of this tumor<br />
subtype. The construction of comprehensive S/MAR maps of the<br />
region using a panel of breast cancer cell lines may provide information<br />
on relevance for the etiology of breast carcinomas. Changes of<br />
positions of regulatory elements such as S/MAR within the region may<br />
allow an understanding of how the genes in the region are regulated<br />
and how the structural architecture is related to the functional organization<br />
of the DNA.<br />
P05<strong>19</strong>. Expression of two testis-specific genes, TSGA10 and<br />
SYCP3, in skin cancer<br />
M. B. Mobasheri 1 , M. Aarabi 2 , I. Jahanzad 3 , M. H. Modarressi 1,2 ;<br />
1 Department of Medical <strong>Genetics</strong>, Tehran University of Medical Sciences, Tehran,<br />
Islamic Republic of Iran, 2 Reproductive Biotechnology Research Center,<br />
Avesina Research Institute, Tehran, Islamic Republic of Iran, 3 Department of<br />
Pathology, Tehran University of Medical Sciences, Tehran, Islamic Republic of<br />
Iran.<br />
Cancer-testis genes are a group of genes expressed in testicular germinal<br />
cells and a range of human cancers. Testis specific gene A10<br />
(TSGA10) is expressed in testis and actively dividing and fetal differentiating<br />
tissues. SYCP3 gene is supposed to be a testis specific gene<br />
and constitutes the core of the lateral elements of synaptonemal complex.<br />
It has role in regulating DNA binding to the chromatid axis, sister<br />
chromatid cohesion, synapsis, and recombination. Methods: In this<br />
study expression of TSGA10 and SYCP3 were investigated in 26 skin<br />
cancer using RT-PCR. Diagnosis of cancer was based on histopathological<br />
reports. Results: TSGA10 expression was observed in 66.4%<br />
of total of skin tumors including melanomas with 85.7%, Basal cell carcinomas<br />
(BCC) with 75% and Squamous cell carcinomas (SCC) with<br />
40% positive expression of TSGA10, but, SYCP3 transcripts were not<br />
found in skin tumors. Conclusion: These results may get further insight<br />
into the potential role as cancer marker and as cancer testis gene implicated<br />
in tumorogenesis of skin tumors in the case of TSGA10<br />
P0520. Evaluation of the relationship between XRCC1 and XPD<br />
Polymorphisms and laryngeal squamous cell carcinoma (LSCC)<br />
H. Acar 1 , Z. İnan 1 , K. Öztürk 2 ;<br />
1 Dept. of Medical <strong>Genetics</strong>, Selcuk University, Meram Medical Faculty, Konya,<br />
Turkey, 2 Dept. of Otolaryngology, Meram Medical Faculty, Selcuk Unıversıty,<br />
Konya, Turkey.<br />
Squamous cell carcinoma is the most common (90-95%) of all head<br />
and neck cancers (SCCHN), and laryngeal squamous cell carcinoma<br />
(LSCC) is one of the most common tumors of the upper aerodigestive<br />
tract. The incidence varies according to geographical area and most<br />
probably depends on specific environmental risk factors. Many studies<br />
reported that polymorphisms in DNA repair genes reduce their capacity<br />
to repair DNA damage and thereby lead to a greater susceptibility<br />
to cancer. DNA repair enzymes continuously monitor DNA to correct<br />
damaged nucleotide residues generated by exposure to environmen-<br />
1 0<br />
tal mutagenic and cytotoxic compounds or carcinogens. Our objective<br />
was to investigate the association, if any, between XRCC1 (X-ray<br />
repair cross-complementing 1) for Arg399Gln and XPD (ERCC2) for<br />
Lys751Gln polymorphic genotypes and LSCC, smoking and alcohol<br />
habits, tumor-node-metastasis (TNM) classification, and patient age.<br />
There was no significant difference in the genotype distribution of XPD<br />
between LSCC patients and their smoking and alcohol habits, tumornode-metastasis<br />
(TNM) classification, and patient age and controls for<br />
each polymorphism (p>0.05). There was a significant difference between<br />
the genotype distributions of XRCC1 in patients and in control<br />
groups (P